JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1985) 104, 447-452       DOI: 10.1677/joe.0.1040447
© 1985 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willoughby, J. O.
Right arrow Articles by Judd, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willoughby, J. O.
Right arrow Articles by Judd, S. J.

Responses to prolactin secretagogues in oestrogen-treated rats suggest that the defect in prolactin regulation produced by oestrogen is at the level of the pituitary gland

J. O. Willoughby, H. Pederick, P. Jervois, M. Menadue and S. J. Judd

Prolactin responses to pharmacological agents were used to characterize the defect in prolactin regulation which occurs after administration of high doses of oestrogen to rats.

Animals with chronically implanted venous cannulae were injected with 2 mg oestradiol benzoate in oil and 2–3 days later prolactin concentrations were measured after injections of saline, thyrotrophin-releasing hormone (TRH), fenfluramine, apomorphine and butaclamol. The responses were compared with those in oil-injected animals.

Hyperprolactinaemia in oestrogen-treated animals was unresponsive to apomorphine, but was even more sensitive to dopamine receptor blockade than controls. These results suggest that the lactotrophs in oestrogen-treated animals are already maximally suppressed by endogenous dopamine, though ineffectively.

Although there was an increased prolactin response to TRH in oestrogen-treated animals, there was an impaired response to fenfluramine, indicating suppressed serotonergic prolactin-releasing factor mechanisms.

Maximal endogenous dopaminergic activity and suppressed prolactin-releasing factor mechanisms are appropriate hypothalamic responses to hyperprolactinaemia. The operation of these responses in the earliest stages of the development of pituitary hyperplasia indicates that oestrogen induces a disturbance of prolactin regulation in the lactotroph, independent of hypothalamic control.

J. Endocr. (1985) 104, 447–452




This article has been cited by other articles:


Home page
EndocrinologyHome page
M. E. Cruz-Soto, G. Cosio, M. C. Jeziorski, V. Vargas-Barroso, M. B. Aguilar, A. Carabez, P. Berger, P. Saftig, E. Arnold, S. Thebault, et al.
Cathepsin D Is the Primary Protease for the Generation of Adenohypophyseal Vasoinhibins: Cleavage Occurs within the Prolactin Secretory Granules
Endocrinology, December 1, 2009; 150(12): 5446 - 5454.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Hauspie, E. Seuntjens, H. Vankelecom, and C. Denef
Stimulation of Combinatorial Expression of Prolactin and Glycoprotein Hormone {alpha}-Subunit Genes by Gonadotropin-Releasing Hormone and Estradiol-17{beta} in Single Rat Pituitary Cells during Aggregate Cell Culture
Endocrinology, January 1, 2003; 144(1): 388 - 399.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
M. Franklin, R.D. Craven, and P.J. Cowen
Effect of castration and castration with hormone replacement on the plasma prolactin responses to neuroendocrine challenge with i.v. mCPP in the male rat following a low tryptophan diet
J Psychopharmacol, January 1, 1996; 10(3): 250 - 253.
[Abstract] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the Society for Endocrinology.